MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL.
MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL.
复制标题
MiR-92b-3p 通过靶向 circCDYL 抑制 HER2 阳性乳腺癌细胞的增殖
DOI:
10.3389/fcell.2021.707049
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Gong C
中科院分区:
文献类型:
--
作者:
Liang G;Ling Y;Lin Q;Shi Y;Luo Q;Cen Y;Mehrpour M;Hamai A;Li J;Gong C
Objectives Circular RNA (circRNA) is a novel class of RNA, which exhibits powerful biological function in regulating cellular fate of various tumors. Previously, we had demonstrated that over-expression of circRNA circCDYL promoted progression of HER2-negative (HER2–) breast cancer via miR-1275-ULK1/ATG7-autophagic axis. However, the role of circCDYL in HER2-positive (HER2+) breast cancer, in particular its role in modulating cell proliferation, one of the most important characteristics of cellular fate, is unclear. Materials and methods qRT-PCR and in situ hybridization analyses were performed to examine the expression of circCDYL and miR-92b-3p in breast cancer tissues or cell lines. The biological function of circCDYL and miR-92b-3p were assessed by plate colony formation and cell viability assays and orthotopic animal models. In mechanistic study, circRNAs pull-down, RNA immunoprecipitation, dual luciferase report, western blot, immunohistochemical and immunofluorescence staining assays were performed. Results CircCDYL was high-expressed in HER2+ breast cancer tissue, similar with that in HER2– breast cancer tissue. Silencing HER2 gene had no effect on expression of circCDYL in HER2+ breast cancer cells. Over-expression of circCDYL promoted proliferation of HER2+ breast cancer cells but not through miR-1275-ULK1/ATG7-autophagic axis. CircRNA pull down and miRNA deep-sequencing demonstrated the binding of miR-92b-3p and circCDYL. Interestingly, circCDYL did not act as miR-92b-3p sponge, but was degraded in miR-92b-3p-dependent silencing manner. Clinically, expression of circCDYL and miR-92b-3p was associated with clinical outcome of HER2+ breast cancer patients. Conclusion MiR-92b-3p-dependent cleavage of circCDYL was an essential mechanism in regulating cell proliferation of HER2+ breast cancer cells. CircCDYL was proved to be a potential therapeutic target for HER2+ breast cancer, and both circCDYL and miR-92b-3p might be potential biomarkers in predicting clinical outcome of HER2+ breast cancer patients.
登录
查看更多内容
影响因子:
4.5
作者:
Marzec M
通讯作者:
Marzec M
DOI:
10.1093/jnci/djx166
发表时间:
2018-03-01
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Yang Y;Gao X;Zhang M;Yan S;Sun C;Xiao F;Huang N;Yang X;Zhao K;Zhou H;Huang S;Xie B;Zhang N
通讯作者:
Zhang N
影响因子:
3.9
作者:
Galvão-Lima LJ;Morais AHF;Valentim RAM;Barreto EJSS
通讯作者:
Barreto EJSS
影响因子:
2.9
作者:
Wang G;Cheng B;Jia R;Tan B;Liu W
通讯作者:
Liu W
影响因子:
37.3
作者:
Liang, Gehao;Ling, Yun;Gong, Chang
通讯作者:
Gong, Chang